Which Probiotic to Take With Your Antibiotic: A Strain-by-Strain Guide

If you’ve just left a doctor’s office with a prescription for an antibiotic, the question of whether to also grab a probiotic is probably bouncing around your head. The short answer is yes. The longer answer is that the specific probiotic depends on which antibiotic you were prescribed, and most articles online don’t make that distinction.

Antibiotic-associated diarrhea hits anywhere from 5 to 35 percent of people, depending almost entirely on which drug.^[5] The high end of that range is Augmentin and clindamycin. The low end is mostly Bactrim, nitrofurantoin, and the narrow-spectrum penicillins.

For a small subset on the high-end drugs, the diarrhea can be the start of a Clostridioides difficile infection. That is the kind of gut crisis where you end up hospitalized for fluid replacement and, in severe cases, a fecal microbiota transplant.

A 2017 Cochrane meta-analysis of 39 trials and nearly 10,000 patients found probiotics co-administered with antibiotics reduced C. difficile infection rates from 4.0 percent to 1.5 percent, a roughly 60 percent relative reduction.^[6] But strain specificity matters.

The right probiotic for Augmentin (LGG, sold as Culturelle) is different from the right one for clindamycin (S. boulardii, a yeast that survives antibacterial coverage). The right one for a Z-Pak differs again. Generic “take a probiotic with antibiotics” advice misses this.

I learned this firsthand.

I got strep in late winter. The urgent care doctor did the swab, came back with the diagnosis, and wrote me for clindamycin hydrochloride. Standard course, three capsules a day, seven days.

I’d taken antibiotics plenty of times before and never thought twice about side effects. But clindamycin kept showing up in the meta-analyses as one of the highest-CDI-risk drugs on the outpatient list. I started reading.

So before I filled the prescription, I spent an afternoon on PubMed.

What stood out reading the Cochrane review carefully: the 60 percent reduction was driven mostly by patients with elevated baseline CDI risk. On clindamycin, I qualified for that subgroup. The probiotic was going to help me more than it would help someone on, say, amoxicillin.

Among the strains studied across the broader literature, Saccharomyces boulardii kept coming up. It is a probiotic yeast, not a bacterium, which means antibiotics targeting bacteria do not kill it.^[14]

What I actually bought: Jarrow Formulas Saccharomyces boulardii + MOS, 5 billion CFU per capsule. Not Florastor, which is the brand with the published clinical trials behind it. The studies used a specific strain code, CNCM I-745, and Florastor is the only product carrying that exact strain.

Jarrow uses a generic S. boulardii without a published strain identifier. I went with Jarrow because that is what my local store stocked. If I’d been picking purely on published evidence, I’d have grabbed Florastor.

I also broke from the textbook on timing. I didn’t start day one. I started day three of the antibiotic course, which is later than the literature suggests is optimal.

The trials that show benefit usually start the probiotic concurrently with the antibiotic. Starting late is still better than not at all, but the mechanism (preserving the gut niche so opportunists can’t bloom) argues for as early as you can manage.

I noticed digestive normalcy within a few days. That is anecdote, n=1, and does not validate the protocol. But I made it through the seven-day clindamycin course without the GI hell I’d read about in case reports.

I kept the probiotic going for two more weeks after the antibiotic ended, because gut microbiome recovery from a single course of antibiotics can take weeks to months per a 2018 Nature Microbiology study.^[3]

What follows is the version of that research, organized by which antibiotic you are on, with the studies that backed each call. I am not a doctor.

I’m a guy who got strep, spent a sick day reading scientific journals on the internet and using AI to help sort through them, then made a plan to test it myself. Either the protocol would work and I’d have material to blog about, or it wouldn’t and I’d spend the next several weeks in close proximity to a toilet.

Table of Contents

• Key Takeaways
• Probiotic-Antibiotic Pairings: The Quick Reference
• Why Antibiotics Need a Probiotic Pairing
  • What antibiotic-associated diarrhea actually is
  • The C. difficile risk: why it matters
  • Broad-spectrum versus narrow-spectrum: why the drug class changes everything
• When to Take Probiotics With Antibiotics
• Penicillins (Amoxicillin, Augmentin, Penicillin V)
• Cephalosporins (Keflex, Omnicef, Ceftin)
• Macrolides (Z-Pak, Biaxin)
• Clindamycin
• Tetracyclines (Doxycycline, Minocycline)
• Fluoroquinolones (Cipro, Levaquin)
• Metronidazole (Flagyl)
• Bactrim (Trimethoprim-Sulfamethoxazole)
• Nitrofurantoin (Macrobid)
• Special Cases: Vancomycin, Fidaxomicin, Rifaximin, Fosfomycin
  • Oral vancomycin (Vancocin)
  • Fidaxomicin (Dificid)
  • Rifaximin (Xifaxan)
  • Fosfomycin (Monurol)
• Saccharomyces boulardii Safety: Who Should Never Take It
• Do Yogurt, Kefir, and Fermented Foods Count?
• Who Shouldn’t Take Probiotics During Antibiotics
• Recovery Timeline: What to Expect After Your Antibiotic Course Ends
• Frequently Asked Questions
  • When should I take probiotics with antibiotics?
  • What probiotic should I take with antibiotics?
  • How long should I take probiotics after antibiotics?
  • Can I take probiotics and antibiotics at the same time?
  • Will my regular daily probiotic work, or do I need a specific strain?
  • Is Saccharomyces boulardii safe with antibiotics?
  • Does yogurt or kefir count as a probiotic for antibiotic side effects?
  • Are there people who shouldn’t take probiotics during antibiotics?
  • What’s the best probiotic for women on antibiotics?
  • Do probiotics make antibiotics less effective?
  • What if I’m on multiple antibiotics at once?
  • Does Saccharomyces boulardii actually prevent C. difficile?
  • What’s the difference between Lactobacillus rhamnosus GG and other Lactobacillus strains?
  • Can I take probiotics if I’m pregnant or breastfeeding?
  • Why do some studies show probiotics don’t help?
• Bottom Line
• Article Updates
• Sources

Key Takeaways

• The right probiotic depends on the antibiotic. Not all probiotics work for all drugs. Match the strain to the drug class.
• Saccharomyces boulardii (a yeast probiotic) is the best-evidenced choice for clindamycin, fluoroquinolones, and macrolides, because it survives antibacterial coverage and reduces C. difficile risk.^[6,14]
• Lactobacillus rhamnosus GG (LGG, sold as Culturelle) is the best-evidenced choice for penicillins, cephalosporins, tetracyclines, and most other classes where general antibiotic-associated diarrhea prevention is the goal.^[18]
• Take the probiotic at least two hours apart from the antibiotic dose.^[17] For yeast probiotics like S. boulardii, the timing rule is moot in mechanism but useful for routine.
• Continue the probiotic for two to four weeks after the antibiotic ends. Gut microbiome recovery is gradual; Nature Microbiology 2018 found common beneficial species still missing six months after a single broad-spectrum course.^[3]
• Some people should not take probiotics during antibiotics. Central venous catheter, severe immunocompromise, ICU-level critical illness, severe acute pancreatitis. When in doubt, ask your doctor.
• Probiotics are not magic. The PLACIDE trial (n=2,941 elderly UK inpatients) found no benefit from a generic multistrain product.^[15] Strain specificity and population matter.

Probiotic-Antibiotic Pairings: The Quick Reference

This is the table I wish someone had handed me before I walked into the pharmacy. Find your antibiotic in the left column. Match the strain in the second column. Dose in the third. Strength of evidence in the fourth (A = multiple RCTs or Cochrane review supports this strain for this class; B = limited class-specific RCTs, primary evidence is a strain-specific or general antibiotic-associated diarrhea meta-analysis applied here; C = mechanism plus class extrapolation, drug-specific RCT evidence is thin). Citation in the fifth. Product I’d actually buy in the sixth.

The dagger symbol (†) after a citation means it is a general antibiotic-associated diarrhea or C. difficile meta-analysis applied to this drug class, not a class-specific trial. Class-specific evidence is discussed in each drug section below.

Antibiotic	Probiotic Strain	Daily Dose	Evidence	Primary Citation	Product
Amoxicillin, Augmentin, Penicillin, Ampicillin, Dicloxacillin	L. rhamnosus GG	10-20B CFU	A	Szajewska & Kolodziej 2015 (AP&T)	Culturelle Daily
Cephalexin (Keflex), Cefdinir (Omnicef), Cefuroxime, Cefpodoxime, Cefaclor, Cefixime	L. rhamnosus GG or S. boulardii	10B / 5B CFU	B	Goldenberg 2017 (Cochrane)†	Culturelle or Florastor
Azithromycin (Z-Pak), Clarithromycin (Biaxin), Erythromycin	S. boulardii CNCM I-745	5-10B CFU	B	Szajewska 2015 S. boulardii meta†	Florastor
Clindamycin	S. boulardii (CNCM I-745 preferred; any S. boulardii reasonable)	5-10B CFU	A (CDI-specific)	Goldenberg 2017 (Cochrane)	Florastor or Jarrow S. boulardii + MOS (what I used)
Doxycycline (Vibramycin), Minocycline (Minocin), Tetracycline	L. rhamnosus GG	10B CFU	C	Szajewska & Kolodziej 2015 (AP&T)†	Culturelle
Ciprofloxacin (Cipro), Levofloxacin (Levaquin), Moxifloxacin (Avelox), Ofloxacin	S. boulardii + multi-strain Lactobacillus	5-10B + 25-50B CFU	B	Hempel 2012 (JAMA)†	Florastor + Visbiome
Metronidazole (Flagyl), Tinidazole (Tindamax)	L. rhamnosus GG or S. boulardii	10B CFU / 5-10B CFU	C	Allen 2013 (Cochrane)† + McFarland 1994	Culturelle or Florastor
Bactrim / Septra (Trimethoprim-Sulfamethoxazole)	L. rhamnosus GG	10B CFU	C	Hempel 2012 (JAMA)†	Culturelle
Nitrofurantoin (Macrobid / Macrodantin)	L. rhamnosus GG (often not necessary)	10B CFU	C	Hempel 2012†; Vervoort 2015 (minimal need)	Culturelle
Oral Vancomycin (Vancocin), for C. diff treatment	S. boulardii (with GI specialist consult)	5-10B CFU	C	McFarland 1994 (JAMA)	Florastor
Fidaxomicin (Dificid), for C. diff treatment	Generally not needed during treatment	n/a	n/a (narrow-spectrum, microbiome-sparing)	Louie 2012 (CID)	n/a
Rifaximin (Xifaxan), for IBS / SIBO / hepatic encephalopathy	Depends on indication; L. rhamnosus GG if AAD develops	10B CFU	C	Pimentel 2011 (NEJM) + Oh 2025 (Nutrients)	Culturelle
Fosfomycin (Monurol), single-dose UTI	Generally not needed	n/a	n/a	IDSA UTI guidelines	n/a

Why Antibiotics Need a Probiotic Pairing

Antibiotics save lives. They also flatten the gut microbiome on their way past. The trillion-or-so microbes in your colon are not just along for the ride. They produce short-chain fatty acids that feed the cells lining your intestine, train your immune system, occupy ecological niches that pathogens would otherwise colonize, and metabolize a meaningful chunk of the compounds you eat.^[1]

A 2018 Nature Microbiology study followed twelve healthy young men through a four-day course of a broad-spectrum antibiotic cocktail and tracked their gut communities for six months. Most species came back, slowly. Nine common beneficial species were still missing at six months, and a few opportunistic colonizers had moved in.^[3]

That study used three IV antibiotics simultaneously, far heavier than a typical outpatient prescription. But even a single course of oral ciprofloxacin disrupted about one-third of all bacterial taxa within days, and a second course months later pushed the gut into an alternative stable state that lasted at least two months, per a 2011 PNAS study.^[2]

What antibiotic-associated diarrhea actually is

The clinical term is antibiotic-associated diarrhea, or AAD. The 2002 New England Journal of Medicine review by John Bartlett (the late infectious-disease specialist who first described the link between clindamycin and pseudomembranous colitis in the 1970s) sets the baseline range at 5 to 35 percent across commonly prescribed antibiotics, with the wide range driven almost entirely by which drug.^[5]

Augmentin (amoxicillin-clavulanate) sits near the top, with adult studies reporting 10 to 25 percent and pediatric trials of older formulations hitting 26.7 percent.^[5,18] Tetracyclines and Bactrim sit closer to the bottom of the range, often under 10 percent. Nitrofurantoin causes essentially no measurable change in gut microbiome composition because it concentrates in the urinary tract and barely reaches the colon.^[23]

Mechanism: most AAD is osmotic (undigested carbohydrates pulling water into the colon because the bacterial fermentation machinery has been knocked back) or related to direct bile-acid metabolism changes. Some of it is inflammatory. A subset, the dangerous subset, is C. difficile.

The C. difficile risk: why it matters

Clostridioides difficile is a spore-forming bacterium that lives quietly in some people’s guts at low population levels. The protective species (Bacteroidetes, certain Firmicutes) keep it in check. When an antibiotic clears the protective species, C. difficile can bloom, produce toxins, and trigger anything from a few days of explosive diarrhea to a hospital admission for severe colitis.

The 2005 Quebec outbreak that introduced the hypervirulent NAP1/027 strain to clinical attention sat at a 36 percent fatality rate at 30 days in the worst-affected cohorts.^[8]

Goldenberg’s 2017 Cochrane meta-analysis, the pivotal piece of evidence for probiotic C. diff prevention, pooled 39 trials and 9,955 immunocompetent patients on antibiotics.^[6] Headline result: CDI incidence dropped from 4.0 percent on placebo to 1.5 percent on probiotics. Relative risk 0.40, confidence interval 0.30 to 0.52. Moderate-certainty evidence per the GRADE framework.

The caveat that matters: the effect was overwhelmingly driven by patients whose baseline CDI risk was already above five percent. In the lower-risk subgroup, the relative risk was 0.77 with a confidence interval that crossed unity. In the higher-risk subgroup, the relative risk was 0.30 (a 70 percent reduction). The headline number is not wrong. The interpretation is: probiotics help most when you actually need them. A 25-year-old on amoxicillin for a sinus infection sees a small absolute risk reduction. A 70-year-old on clindamycin in a hospital sees a large one.

Broad-spectrum versus narrow-spectrum: why the drug class changes everything

Broad-spectrum antibiotics hit a wide range of bacteria. Amoxicillin-clavulanate, clindamycin, the fluoroquinolones, the cephalosporins. These produce more dysbiosis, more AAD, and more C. difficile risk.^[7,9] Narrow-spectrum antibiotics target a tighter list. Penicillin V for strep, fidaxomicin for C. diff itself, nitrofurantoin for uncomplicated cystitis. These produce less collateral damage.

One nuance worth surfacing: macrolides specifically cause long-lasting changes that penicillins do not. A 2016 Nature Communications study of 142 Finnish preschoolers linked individual macrolide prescriptions to depleted Actinobacteria and increased macrolide resistance in fecal samples, while penicillin courses did not produce the same durable shifts.^[4]

When the article tells you to pair S. boulardii with a Z-Pak, that is the mechanism support: the macrolide will cause a longer-lasting gut shift than the prescription receipt suggests.

When to Take Probiotics With Antibiotics

The two-hour rule

The standard clinical guidance: separate the probiotic dose from the antibiotic dose by at least two hours.^[17] The mechanism is intuitive. If you take a live bacterial probiotic at the same time as the antibiotic, the gastric peak concentration of the drug will inactivate a chunk of the probiotic bacteria before they reach the lower intestine where they are supposed to work.

The pharmacy review I leaned on for this is from the American Journal of Health-System Pharmacy 2010 (Williams), which gives the recommendation verbatim.^[17]

One real-world note: for Saccharomyces boulardii (a yeast), the rule is functionally moot because antibacterial antibiotics do not act on fungi. S. boulardii survives the gastric coexistence intact. Most guidelines still apply the two-hour rule for yeast probiotics out of routine consistency, not because of mechanism.

If you forget the spacing and take both together with breakfast, you have not ruined anything. The next dose is fine.

The bigger adherence point is daily consistency. The trials that show benefit had patients taking the probiotic every day for the duration of the antibiotic course (plus often weeks after). Skipping doses to honor perfect spacing is worse than taking the dose imperfectly.

How long to continue after your antibiotic course ends

Most RCTs that show benefit continued the probiotic for one to three weeks past the end of the antibiotic. My personal protocol, based on the Palleja 2018 microbiome-recovery data, is two to four weeks past the end of the course.^[3]

Palleja’s six-month follow-up still showed missing beneficial species, so the truth is that gut recovery is slow and any probiotic-supported colonization is incremental. If you had AAD during the course, lean toward the longer end (four weeks or even six).

If you are treating a child

The European pediatric gastroenterology society (ESPGHAN) issued formal guidance in 2016 recommending L. rhamnosus GG at 1 to 2 x 10¹⁰ CFU per day, or S. boulardii at 250 to 500 milligrams per day, for children receiving antibiotics where AAD prevention is a goal.^[33] A 2015 Cochrane review of 23 pediatric RCTs supports the recommendation with moderate-quality evidence and a low adverse-event rate.^[34] Two products to look for: Florastor Kids (powder sachets that mix into food, with the CNCM I-745 strain explicitly labeled and approved for use with antibiotics) or Culturelle Kids Chewable.

How to read a probiotic label

Probiotics are regulated as dietary supplements in the United States, which means the label is partly your responsibility. Four things to check before you buy:

• The full strain name, not just the species. “Lactobacillus rhamnosus” is the species. “L. rhamnosus GG” or “L. rhamnosus ATCC 53103″ is the strain. Different strains within a species can behave very differently in clinical trials. McFarland’s 2018 Frontiers in Medicine review found that of six tested Lactobacillus strains for adult AAD, only four had significant efficacy.^[16] The strain code matters.
• CFU at expiration, not at manufacture. Some products print the count at manufacture (which can be 10x the count at the bottle’s expiration date). Look for “guaranteed through expiration” or similar wording.
• Storage requirements. Some strains require refrigeration. Some are shelf-stable. The label tells you which.
• Third-party verification. USP, NSF, ConsumerLab. These are not perfect, but they screen out the worst offenders for purity and label accuracy.

Penicillins (Amoxicillin, Augmentin, Penicillin V)

The penicillin family is the broadest single category of outpatient antibiotic, and amoxicillin alone accounts for 21 percent of all US outpatient antibiotic prescriptions per the 2022 CDC report.^[32] Strep throat, otitis media, sinusitis, dental infections, simple skin infections.

The active mechanism (interfering with bacterial cell wall synthesis) is shared across the class, which is why one recommendation covers them all.

Drug	Brand	Common use	AAD risk	Probiotic pairing
Penicillin V (oral)	(generic)	Strep throat, mild infections	Low (≤5%)	LGG (Culturelle), 10B CFU
Penicillin G	(injection)	Syphilis, severe strep	Low	LGG (Culturelle) if oral follow-up
Amoxicillin	(generic)	Ear infections, sinusitis, dental, strep	Moderate (5-10%)	LGG (Culturelle), 10-20B CFU
Augmentin (amoxicillin + clavulanate)	Augmentin	Resistant ear and sinus, dog bites, complicated UTI	High (10-25%; up to 27% in pediatric trials)	LGG (Culturelle Pro Strength), 20B CFU + strict 2-hour spacing
Ampicillin	(generic)	Bacterial endocarditis, listeriosis	Low-moderate (5-10%)	LGG (Culturelle), 10B CFU
Dicloxacillin	(generic)	Skin infections (MSSA)	Low (5-10%)	LGG (Culturelle), 10B CFU

What penicillins do to your gut

The Korpela 2016 study of Finnish preschoolers found that penicillin courses produced essentially no long-lasting microbiome shifts, even though they caused short-term AAD in a subset of children.^[4] Penicillins are the cleanest broad-spectrum class in terms of durable gut consequences. The probiotic recommendation here is about acute AAD prevention, not long-term microbiome insurance.

Augmentin is the asterisk. The clavulanate component (a beta-lactamase inhibitor co-formulated to extend amoxicillin’s spectrum) has a documented prokinetic-and-osmotic effect on the gut that drives the AAD rate up to the top of the penicillin family range, hitting 26.7 percent diarrhea in one pediatric trial of an older formulation.^[18]

If you are on Augmentin, the probiotic is more useful than if you are on plain amoxicillin.

What to take and why

L. rhamnosus GG, 10 to 20 billion CFU daily. The supporting evidence is Szajewska and Kolodziej’s 2015 Alimentary Pharmacology and Therapeutics meta-analysis of 12 RCTs covering 1,499 patients.^[18] LGG reduced AAD risk from 22.4 percent to 12.3 percent across the pooled population.

The significance was driven mostly by the pediatric subgroup. Adult data is more mixed, and that mixedness is real, not marketing.

How and when to take it

Two hours apart from each amoxicillin or Augmentin dose. Continue daily for the duration of the course plus two more weeks. With food is fine.

What I’d buy if I were on a penicillin: Culturelle Daily Probiotic, 10 billion CFU LGG, one capsule per day. For a longer course (15+ days), the Culturelle Pro Strength 60-count covers two months at a per-capsule discount.

Cephalosporins (Keflex, Omnicef, Ceftin)

Cephalosporins share the beta-lactam mechanism with penicillins but extend the antibacterial spectrum. They are first-line for many skin and soft tissue infections (cephalexin) and for resistant pediatric otitis media (cefdinir).

They are also one of the IDSA’s flagged high-CDI-risk drug classes in the 2017 antimicrobial-stewardship guidelines, alongside clindamycin and fluoroquinolones.^[9]

Drug	Brand	Common use	AAD risk	Probiotic pairing
Cephalexin	Keflex	Skin and soft tissue, mild UTI	10-15%	LGG (Culturelle) or S. boulardii (Florastor)
Cefdinir	Omnicef	Pediatric ear infections, sinusitis	10-15%	LGG (Culturelle) or Florastor Kids
Cefuroxime	Ceftin	Sinusitis, Lyme disease (early)	10-15%	LGG (Culturelle) or S. boulardii (Florastor)
Cefpodoxime	Vantin	Bronchitis, sinusitis	10-15%	LGG (Culturelle)
Cefadroxil	Duricef	Strep throat, skin infections	10-15%	LGG (Culturelle)
Cefaclor	Ceclor	Ear, sinus, throat (older drug)	10-15%	LGG (Culturelle)
Cefixime	Suprax	Gonorrhea, UTI, ear infections	15-20%	LGG (Culturelle Pro Strength), 20B CFU

What cephalosporins do to your gut

Cephalosporins disrupt anaerobic gut flora and produce moderate AAD across the class. In children, an outpatient cohort study (Damrongmanee 2007) reported 14.4 percent AAD with cephalosporins, comparable to the high-end penicillin numbers.^[5]

The CDI risk is the more important consideration: cephalosporins consistently rank in the top tier of antibiotic classes for community-acquired CDI risk per the 2013 Brown meta-analysis (odds ratio around 5).^[7]

What to take and why

Either L. rhamnosus GG at 10 billion CFU or S. boulardii at 5 billion CFU is reasonable. If you are an outpatient adult with low baseline CDI risk, LGG is fine.

If you are elderly, recently hospitalized, or being prescribed a long course or a high-CDI-risk cephalosporin like cefdinir for a complicated infection, lean toward S. boulardii for the better CDI-prevention evidence.^[6,14]

How and when to take it

Two hours apart from each cephalosporin dose. Daily for the full course plus two weeks after.

What I’d buy: For most cephalexin courses, Culturelle Daily. For a longer or higher-risk course, Florastor.

Macrolides (Z-Pak, Biaxin)

The macrolide class is the second most-prescribed antibiotic class in US outpatient settings, with azithromycin alone at 14.8 percent of all prescriptions per the 2022 CDC report.^[32] Z-Pak (the five-day azithromycin pack) is reflexively prescribed for upper respiratory infections, often viral ones where it does nothing.

That overprescription is a separate problem; the gut consequences are not.

Drug	Brand	Common use	AAD risk	Probiotic pairing
Azithromycin	Z-Pak, Zithromax	Respiratory infections, pertussis, chlamydia	5-10%	S. boulardii (Florastor), 5-10B CFU
Clarithromycin	Biaxin	H. pylori treatment, pneumonia	5-10%	S. boulardii (Florastor), 5-10B CFU
Erythromycin	Ery-Tab, Erythrocin	Older respiratory infections, gastroparesis (off-label)	10-20% (prokinetic effect inflates apparent diarrhea)	S. boulardii (Florastor), 5-10B CFU

What macrolides do to your gut

The Korpela 2016 study found that macrolides cause long-lasting shifts in pediatric gut microbiota that penicillins do not produce.^[4] Specifically: Actinobacteria depleted, Bacteroidetes and Proteobacteria increased, bile-salt hydrolase activity reduced, macrolide-resistance genes enriched.

These shifts persisted well past the end of the antibiotic course. There is no macrolide-specific probiotic RCT (a real gap in the literature), but the mechanism evidence is strong enough that a probiotic pairing is justified even though the strength-of-evidence tier is B rather than A.

One quirk worth knowing: erythromycin acts on motilin receptors in the gut and accelerates gastric emptying. Some of what feels like AAD on erythromycin is actually prokinetic-driven, not microbiome-driven.

A probiotic will not solve that part. If your “antibiotic diarrhea” on erythromycin is really just everything moving faster, the probiotic will not fix it.

What to take and why

Saccharomyces boulardii CNCM I-745, 5 to 10 billion CFU daily. Szajewska’s 2015 S. boulardii meta-analysis pooled 21 RCTs and 4,780 participants and found a 53 percent reduction in AAD risk.^[19]

The data is not macrolide-specific (none of the meta-analyses are), but the strain has the strongest general AAD evidence and the macrolide mechanism (durable dysbiosis) argues for the more aggressive intervention.

How and when to take it

Once daily during the Z-Pak’s five days, then continue for two more weeks. Spacing from the antibiotic is less important for the yeast (it survives the antibacterial anyway), but I take it at a different time of day just for routine.

What I’d buy: Florastor. The CNCM I-745 strain is what the studies tested.

Clindamycin

This is my section, the drug I was on, the reason this article exists.

Clindamycin carries the highest Clostridioides difficile infection risk of any commonly prescribed outpatient antibiotic. The Brown 2013 meta-analysis of community-acquired CDI puts clindamycin at an odds ratio around 20 versus no antibiotic exposure.^[7] A more recent 2022 analysis by Miller and colleagues found clindamycin OR 25.39 within 30 days of exposure and 17.19 within 90 days.

The original 1974 prospective study by Tedesco found 21 percent AAD and 10 percent pseudomembranous colitis in patients on clindamycin alone, before C. diff was even named.

Clindamycin works. It is one of the best drugs we have for dental infections, certain soft tissue infections (especially when MRSA is suspected), and as a strep alternative for people with penicillin allergy. Mine was for strep, with the penicillin path off the table for an allergy reason.

The reason the doctor and I both nodded when she handed over the prescription is that clindamycin is effective. The reason I went home and read for four hours is that it is also the drug most likely to land you in a hospital bed with a Bristol Stool Chart 7 problem.

What to take and why

Saccharomyces boulardii, 5 to 10 billion CFU daily. CNCM I-745 (the Florastor strain) has the most published evidence (130+ clinical trials), but any S. boulardii product is reasonable if Florastor is not available locally.

Why the yeast and not a Lactobacillus: clindamycin is an antibacterial. It does not kill yeasts. S. boulardii survives the antibiotic course intact, occupies gut niches that depleted commensal bacteria would otherwise hold, and reduces C. difficile colonization.^[14]

A Lactobacillus probiotic taken at the same time gets partly inactivated by the antibiotic in the gastric coexistence, even with the two-hour spacing rule. The yeast bypasses the whole problem.

The pivotal evidence is Goldenberg’s 2017 Cochrane review, specifically the higher-risk subgroup where baseline CDI rate was above five percent.^[6] Relative risk 0.30, confidence interval 0.21 to 0.42. A 70 percent reduction. That subgroup is exactly the clindamycin population.

McFarland’s 1994 JAMA RCT (the foundational trial of S. boulardii as a CDI adjunct) found a 30-point absolute reduction in recurrent CDI when S. boulardii was added to standard antibiotic treatment.^[20]

An alternative with similarly good CDI-prevention evidence: Bio-K+ DailyCare, the multistrain Lactobacillus formulation (CL1285 + LBC80R + CLR2) that was studied in the Gao 2010 dose-ranging RCT.^[22] Double-dose (100 billion CFU) reduced CDI incidence from 23.8 percent to 1.2 percent in 255 adult inpatients on high-risk antibiotics.

Bio-K+ uses bacteria not yeast, but the strain combination has its own published evidence specifically for CDI prevention. If you are choosing between Florastor and Bio-K+ for clindamycin coverage, both are evidence-supported. I picked the yeast because of the mechanism (no antibiotic interaction).

What I actually did

Bought Jarrow Formulas S. boulardii + MOS, 5 billion CFU per capsule. The Jarrow product uses a generic S. boulardii strain without a published strain code (verified against the Jarrow product page) rather than the CNCM I-745 that Florastor uses.

The MOS (manno-oligosaccharide) component is a yeast-derived prebiotic that, in theory, helps the probiotic colonize. The “in theory” is doing work in that sentence. There is no head-to-head data comparing Jarrow’s generic strain to Florastor’s CNCM I-745.

I took one capsule twice a day starting day three of the seven-day clindamycin course. Day one would have been better. I continued the Jarrow for two more weeks after the antibiotic ended, which gets me into the recovery-period coverage Palleja 2018 supports.^[3]

I made it through without GI consequences. That is n=1 anecdote. The randomized data is what the recommendation rests on.

How and when to take it

Day one of the antibiotic, ideally. Two hours apart from the clindamycin dose (more out of routine than mechanism for the yeast). Continue daily for the full course plus three to four weeks after. If you had any AAD during the course, extend to six weeks.

What I’d buy: Florastor 100 capsules if I were picking purely on published evidence. Jarrow S. boulardii + MOS 90 capsules at roughly a third the price if I were picking on cost-and-availability and willing to trust the broader S. boulardii class evidence rather than the strain-specific data. Both are reasonable.

Tetracyclines (Doxycycline, Minocycline)

Tetracyclines are the antibiotic class where the probiotic case is real but not urgent. Doxycycline is first-line for early Lyme disease, acne (often long courses, sometimes months), pneumonia in penicillin-allergic patients, and a range of tropical and tick-borne infections.

The CDI risk is one of the lowest of any commonly prescribed antibiotic; Brown 2013 ranks doxycycline near the bottom of the community-acquired CDI hierarchy.^[7]

Drug	Brand	Common use	AAD risk	Probiotic pairing
Doxycycline	Vibramycin, Doryx	Acne, Lyme disease, pneumonia, malaria prophylaxis	5-10%	LGG (Culturelle), 10B CFU
Minocycline	Minocin, Solodyn	Acne (often long courses)	5-10%	LGG (Culturelle), 10B CFU
Tetracycline	Sumycin (generic)	H. pylori adjunct, older infections	5-10%	LGG (Culturelle), 10B CFU

What to take and why

L. rhamnosus GG, 10 billion CFU daily. There is no tetracycline-specific probiotic RCT. The recommendation rests on Szajewska 2015’s general LGG meta-analysis applied to this class.^[18] I want to be honest about that: the evidence here is class-extrapolated, not class-specific.

For acne courses that run several months, the case for a daily probiotic gets stronger as the cumulative exposure grows. For a 10-day doxy course for early Lyme, the AAD risk is low enough that a probiotic is reasonable but not essential.

If you skip it for a short doxy course and you tolerate the antibiotic without issue, you have not made a mistake.

How and when to take it

Two hours apart from each doxycycline dose. Doxycycline binds to calcium, magnesium, iron, and zinc (most multivitamins, dairy), so absorption is a separate issue from probiotic timing. Take the antibiotic on an empty stomach when possible, take the probiotic with food two hours later.

What I’d buy: Culturelle Daily Probiotic.

Fluoroquinolones (Cipro, Levaquin)

The fluoroquinolones are the class that worried me second most after clindamycin. Ciprofloxacin and levofloxacin are still routinely prescribed for UTIs, prostatitis, and some respiratory infections, despite the FDA black box warning about tendon rupture, peripheral neuropathy, and CNS effects. Their gut consequences are also severe.

Dethlefsen and Relman’s 2011 PNAS study showed that a single 5-day course of ciprofloxacin influenced about one-third of all bacterial taxa within days, and a second course months later did not fully reset.^[2] The 2005 Quebec CDI outbreak that introduced the hypervirulent NAP1/027 strain was driven largely by fluoroquinolone prescribing.^[8]

Drug	Brand	Common use	AAD risk	Probiotic pairing
Ciprofloxacin	Cipro	UTI, prostatitis, traveler’s diarrhea	5-15%	S. boulardii (Florastor) + multi-strain (Visbiome)
Levofloxacin	Levaquin	Pneumonia, complicated UTI	5-15%	Florastor + Visbiome
Moxifloxacin	Avelox	Respiratory infections	5-15%	Florastor + Visbiome
Ofloxacin	Floxin	Otic infections, older systemic use	5-15%	Florastor + Visbiome
Gemifloxacin	Factive	Bronchitis exacerbations	5-15%	Florastor + Visbiome

What to take and why

This is the section where I would layer two products. S. boulardii 5 to 10 billion CFU (yeast probiotic, survives the antibiotic, reduces CDI risk) plus a high-CFU multi-strain Lactobacillus like Visbiome at 25 to 50 billion CFU per day.

The layered approach is not from a single RCT; it is mechanism-based reasoning supported by Hempel’s 2012 broad AAD meta-analysis^[13] and the Bartoletti 2021 retrospective showing 0 percent CDI in fluoroquinolone-treated patients on probiotics versus 3 percent in those who weren’t (small cohort, not statistically significant, but directionally consistent).

If you only take one, take the S. boulardii. The CDI prevention is what matters most with this class.

How and when to take it

Two hours apart from each fluoroquinolone dose. Fluoroquinolones, like tetracyclines, are chelated by divalent cations (calcium, magnesium, iron, zinc, antacids), so the absorption-related spacing rules are about food and supplements, separate from probiotic timing.

Special notes

If you are on a fluoroquinolone, also know about the tendon rupture warning. Avoid heavy weight training and any new high-impact activity during and for two weeks after the course. This is not a probiotic issue, but it is the kind of thing I wish someone had told me before my first cipro prescription.

What I’d buy: Florastor for the CDI prevention plus Visbiome 60 capsules for the high-CFU multistrain coverage.

Metronidazole (Flagyl)

Metronidazole is selective for anaerobic bacteria and protozoa. It is the workhorse for bacterial vaginosis, trichomoniasis, giardia, certain dental infections, and (until recently) initial-episode C. difficile treatment.

The metronidazole gut signature is mostly Bacteroides depletion, with downstream effects on short-chain fatty acid production and bile-acid metabolism. AAD incidence with metronidazole is comparatively low (under 5 percent in most series), but the dysbiosis profile is real.

Drug	Brand	Common use	AAD risk	Probiotic pairing
Metronidazole	Flagyl	Bacterial vaginosis, giardia, dental infections	<5%	LGG (Culturelle) or S. boulardii (Florastor)
Tinidazole	Tindamax	Trichomoniasis, giardia (newer alternative)	<5%	LGG (Culturelle) or S. boulardii (Florastor)

The myth about S. boulardii and metronidazole

There is an old internet rumor that you should not take Saccharomyces boulardii with metronidazole. The clinical literature does not support that. McFarland’s 1994 JAMA trial directly co-administered S. boulardii with metronidazole (and with vancomycin) in patients being treated for active C. difficile infection, and showed both safety and benefit (in the recurrent CDI subset).^[20]

S. boulardii is a yeast. Metronidazole is selective for anaerobic bacteria and protozoa, not yeasts. The combination is fine.

Use LGG (10 billion CFU) or S. boulardii (5 to 10 billion CFU). Either is reasonable.

How and when to take it

Two hours apart from each metronidazole dose. Do not drink alcohol during the course; metronidazole produces a severe disulfiram-like reaction with alcohol (nausea, vomiting, flushing) that lasts a few days past the last dose.

What I’d buy: Culturelle Daily for routine use, or Florastor if you also want the yeast benefit (no antibiotic interaction at all).

Bactrim (Trimethoprim-Sulfamethoxazole)

Bactrim and Septra are the two brand names for the same combination: trimethoprim plus sulfamethoxazole. The most common outpatient uses are uncomplicated UTI, skin and soft tissue infection (especially when MRSA is suspected), and pediatric otitis media in penicillin-allergic kids.

Bactrim’s CDI risk profile is on the lower end (Brown 2013 ranks it near doxycycline), and its AAD incidence is in the 5 to 10 percent range.^[5,7]

What to take and why

L. rhamnosus GG at 10 billion CFU. The evidence is Szajewska 2015^[18] and Hempel 2012^[13] applied to this class. No Bactrim-specific RCT exists.

Worth being honest: Bactrim is one of the classes where the urgency of the probiotic recommendation is lowest. If you skip it for a 3-day Bactrim course for a simple UTI and tolerate the antibiotic without issue, you have not made a mistake.

The recommendation is here for completeness, not for clinical urgency. Overrecommending probiotics for low-risk drugs would dilute the more important recommendations elsewhere.

How and when to take it

Two hours apart from each Bactrim dose. Drink plenty of water (Bactrim crystallizes in concentrated urine).

What I’d buy: Culturelle Daily, or skip it for a short course.

Nitrofurantoin (Macrobid)

Nitrofurantoin is the antibiotic where I’ll say the quiet part out loud: most people on a 5-day Macrobid course for a simple UTI do not actually need a probiotic. The drug concentrates in urine and barely reaches the colon at meaningful levels.

A 2015 Journal of Antimicrobial Chemotherapy metagenomics study found nitrofurantoin had no significant global impact on gut microbiota composition compared to baseline, while a paired ciprofloxacin arm in the same protocol showed the expected severe dysbiosis.^[23]

What to take and why

If you have a history of GI sensitivity to antibiotics, take L. rhamnosus GG at 10 billion CFU. If you do not, you can reasonably skip the probiotic for a 5-day Macrobid course. The evidence does not support it as a default recommendation, and I will not pretend otherwise.

For longer nitrofurantoin courses (occasionally prescribed for chronic UTI suppression in older adults), the case for a daily probiotic is more reasonable on cumulative-exposure grounds.

What I’d buy: Probably nothing for a 5-day course. Culturelle Daily if a longer course or if you have GI sensitivity history.

Special Cases: Vancomycin, Fidaxomicin, Rifaximin, Fosfomycin

Four antibiotics that do not fit the standard pairing logic. Each has an unusual gut profile.

Oral vancomycin (Vancocin)

Used to treat C. difficile infection, not to cause it. If you are prescribed oral vancomycin, you have either active CDI or a recurrent CDI history. McFarland 1994 tested S. boulardii as an adjunct to vancomycin (and metronidazole) for active CDI treatment and found benefit only in the recurrent-CDI subgroup.^[20]

The AGA 2020 guideline does not recommend probiotics for CDI treatment outside clinical trials.^[11] If you are being actively treated for CDI, talk to your GI specialist before adding a probiotic. Self-prescribing during active CDI treatment is the wrong move.

Fidaxomicin (Dificid)

Narrow-spectrum CDI treatment. Fidaxomicin acts almost exclusively on Clostridium, leaving Bacteroidetes and most commensal anaerobes intact per the Louie 2012 microbiome study.^[24]

A probiotic is generally not needed during a fidaxomicin course because the antibiotic is so microbiome-sparing. The 2021 IDSA update prefers fidaxomicin over vancomycin for both initial and recurrent CDI partly for this reason.^[10]

Rifaximin (Xifaxan)

Minimally absorbed (under 0.4 percent systemic). Used for IBS-without-constipation (the TARGET trial showed adequate symptom relief in 40.7 percent of patients vs. 31.7 percent on placebo), hepatic encephalopathy, and traveler’s diarrhea.^[25] The 2025 Oh trial in Nutrients tested adding a multistrain Lactobacillus + Bifidobacterium combo to rifaximin for IBS and found combination response rate 65.7 percent versus rifaximin monotherapy 31.4 percent.^[26]

Small single-center study, not yet replicated. For routine rifaximin courses, a probiotic is optional. If you develop AAD on rifaximin (uncommon given the minimal absorption), LGG 10 billion CFU is a reasonable add.

Fosfomycin (Monurol)

Single 3-gram oral dose for uncomplicated UTI. Single-dose exposure minimizes collateral microbiome damage. No probiotic generally needed. If you have GI sensitivity history, one or two days of Culturelle is reasonable. Most people don’t need anything.

Saccharomyces boulardii Safety: Who Should Never Take It

For the population this article is written for (outpatient adults with intact immune systems being prescribed a routine antibiotic course), S. boulardii is safe. The published adverse-event rate at therapeutic outpatient doses is very low.

But there is a population where serious adverse events do occur, and the article would be incomplete without naming it.

The serious adverse event is fungemia, a bloodstream yeast infection. The 2021 Emerging Infectious Diseases case series by Rannikko and colleagues (the most comprehensive recent dataset) collected 20 confirmed S. boulardii fungemia cases from Finnish hospitals between 2009 and 2018.^[30] Common factors: median age 68, central venous catheter present in most, underlying GI disease, ICU admission. Case fatality was 22 percent at day 7 and 37 percent at day 28.

The earlier case-report literature (Cassone 2003, Munoz 2005, Lolis 2008) consistently identifies the same risk factors.^[27,28,29]

The takeaway: S. boulardii should not be used by people with central venous catheters, severe immunocompromise (chemotherapy, organ transplant, advanced HIV), critical illness in an ICU, or recent major thoracic or abdominal surgery.

The 2003 Rome outbreak even suggests that opening S. boulardii capsules in close proximity to a CVC patient can transmit infection through airborne yeast cells colonizing the catheter.^[27]

For an outpatient adult with an intact immune system being prescribed a 7-day clindamycin course for a dental infection, the risk pattern does not apply. The benefit-to-risk ratio strongly favors taking the probiotic. But the risk is not zero, and the article would be dishonest not to name the exception.

Do Yogurt, Kefir, and Fermented Foods Count?

Short answer: not really, when you are on antibiotics.

Yogurt, kefir, sauerkraut, kombucha, and other fermented foods contain live microbes. They contribute to general gut diversity over time and probably to overall health (the evidence for “general probiotic effect from a diverse fermented-food diet” is reasonable but indirect). They are not, however, probiotics in the clinical sense.

The FAO/WHO definition of a probiotic requires named strains at characterized doses with documented health benefits. Yogurt contains live Lactobacillus bulgaricus and Streptococcus thermophilus at variable concentrations that you cannot reliably measure from the carton.

Kefir contains a complex consortium of bacteria and yeasts that varies by brand and even by batch. Kombucha contains a SCOBY-derived microbial community that survives the gastric environment unpredictably. These are what scientists call “live dietary microbes” (LDM), not characterized probiotic strains at clinical doses.

This matters when you are on antibiotics specifically because the strain and dose matter. The 10 billion CFU of L. rhamnosus GG in a Culturelle capsule has been tested in 800+ studies. The unspecified mix of microbes in a cup of yogurt has not.

If you enjoy fermented foods, keep eating them; they are good for you in general. But if you are on clindamycin and you are relying on Greek yogurt for your probiotic coverage, you are bringing the wrong tool. Get the strain-specific capsule.

(For more on the live-microbe side of fermented foods specifically, my kombucha health benefits piece covers what the research actually does and does not support.)

Who Shouldn’t Take Probiotics During Antibiotics

Most outpatient adults are fine. But there are populations where probiotics should be approached with caution or avoided altogether. The AGA 2020 clinical practice guideline lists these contexts explicitly.^[11]

• Severe immunocompromise: active chemotherapy, organ transplant, advanced HIV. The fungemia and bacteremia risk is meaningfully elevated.
• Central venous catheters: the proximate cause of most S. boulardii fungemia cases. If you have a port for chemotherapy, dialysis, or long-term nutrition, talk to your oncologist or nephrologist before any probiotic.
• Critical illness in an ICU: the population in most adverse-event case series.
• Severe acute pancreatitis: the 2008 PROPATRIA trial randomized 296 patients with predicted severe acute pancreatitis to a high-dose multistrain probiotic via jejunal tube versus placebo and found mortality 16 percent on probiotic versus 6 percent on placebo.^[31] The trial was specific to severe acute pancreatitis with jejunal feeding (not a generalizable warning about routine outpatient probiotic use), but the result is real and the population should avoid probiotics until specifically cleared by a gastroenterologist.
• Recent major thoracic or abdominal surgery: follow your surgeon’s post-op guidance.
• Active systemic antifungal therapy: if you are on fluconazole or another systemic antifungal, S. boulardii is functionally inactive (the antifungal will inhibit the yeast). Switch to a Lactobacillus or Bifidobacterium product for the duration.

If you are not in one of these populations, the recommendation above applies as written. If you are, talk to your prescribing doctor before adding anything.

Recovery Timeline: What to Expect After Your Antibiotic Course Ends

The Palleja 2018 Nature Microbiology study is the most relevant single piece of evidence on gut recovery.^[3] Twelve healthy young men took a four-day cocktail of broad-spectrum antibiotics (heavier than a typical outpatient prescription), then provided fecal samples every few weeks for six months.

Most species came back. Nine common beneficial species were still missing at six months. A few opportunistic species had colonized.

For a typical outpatient course (one drug, 5-10 days), the recovery is faster but not instant. Expect:

• Week 1-2 after the course ends: gut function gradually normalizes. Bowel patterns may still be off. Continue the probiotic.
• Week 3-4: most acute symptoms (loose stool, gas, mild discomfort) should be resolved. Continue the probiotic if you had AAD during the course.
• Month 2-6: microbiome composition still drifting back toward baseline. Eat a fiber-rich and fermented-food-rich diet to support the recovery. The probiotic can taper.

Symptoms that should prompt a doctor call (not a wait-and-see): persistent diarrhea (3+ loose stools per day for more than 48 hours after the antibiotic ends), blood in stool, severe abdominal pain, fever above 100.4°F.

These can indicate C. difficile infection, which requires medical treatment and is not something a home probiotic protocol can manage.

Frequently Asked Questions

When should I take probiotics with antibiotics?

Take the probiotic two hours before or after each antibiotic dose, daily during the antibiotic course, and continue for two to four weeks after the course ends.^[17] For yeast probiotics like S. boulardii, the two-hour spacing is mechanistically optional (yeast is unaffected by antibacterial antibiotics) but useful for routine.

What probiotic should I take with antibiotics?

It depends on which antibiotic you are on. For clindamycin, fluoroquinolones, and macrolides, take Saccharomyces boulardii. For penicillins, cephalosporins, tetracyclines, and most other classes, take Lactobacillus rhamnosus GG (Culturelle). The master table at the top of this article maps strain to drug.

How long should I take probiotics after antibiotics?

Two to four weeks minimum. If you experienced any antibiotic-associated diarrhea during the course, extend to six weeks. The Palleja 2018 Nature Microbiology study found gut microbiome composition was still shifted at six months post-exposure, so longer is reasonable.^[3]

Can I take probiotics and antibiotics at the same time?

Not at the same dose. Space them at least two hours apart so the antibiotic does not inactivate the live probiotic in the gastric coexistence. For yeast probiotics (S. boulardii), the spacing is mechanistically moot, but most guidelines apply the same two-hour rule for routine.

Will my regular daily probiotic work, or do I need a specific strain?

Strain matters. McFarland’s 2018 Frontiers in Medicine review found that only four of six tested Lactobacillus strains had significant efficacy for adult antibiotic-associated diarrhea.^[16] The strain on your probiotic label needs to be the one that was studied for the indication you care about. A generic “multistrain probiotic” without specific strain codes is not a substitute for the strain-specific products in this article.

Is Saccharomyces boulardii safe with antibiotics?

Yes, for most outpatient adults with intact immune systems. The safety profile is well-established. The exceptions are central venous catheter patients, severely immunocompromised patients, critical illness in an ICU, and severe acute pancreatitis. For those populations, the fungemia risk documented in the Rannikko 2021 case series is meaningful and the probiotic should not be self-prescribed.^[30]

Does yogurt or kefir count as a probiotic for antibiotic side effects?

Not really. Yogurt and kefir contain live microbes at variable, uncharacterized concentrations. They are good for general gut health, but they are not strain-specific probiotics at clinical doses. If you are on a high-risk antibiotic like clindamycin, get the strain-specific capsule. Eat yogurt too if you want, but do not rely on it as your only probiotic intervention.

Are there people who shouldn’t take probiotics during antibiotics?

Yes. Patients with central venous catheters, severe immunocompromise (chemotherapy, organ transplant, advanced HIV), critical ICU illness, severe acute pancreatitis, or recent major surgery should consult their doctor before adding a probiotic. The AGA 2020 guideline lists these as conditional contraindications.^[11]

What’s the best probiotic for women on antibiotics?

The same strain recommendations apply (match the strain to the drug class). One addition: women on antibiotics frequently develop secondary yeast infections (the antibiotic clears the bacteria that normally compete with Candida). A women’s-specific probiotic that includes Lactobacillus crispatus (e.g., Garden of Life Once Daily Women’s, 50 billion CFU with 16 strains including vaginal-microbiome-supportive species) can supplement the gut probiotic to support vaginal microbiome balance during antibiotic exposure.

Do probiotics make antibiotics less effective?

No. The antibiotic kills the pathogen it was prescribed for; the probiotic occupies gut niches that would otherwise allow opportunists to bloom. The two-hour spacing is to protect the probiotic from being inactivated, not to protect the antibiotic from being interfered with. The antibiotic’s clinical effect on the infection is unchanged.

What if I’m on multiple antibiotics at once?

Default to the strongest pairing recommended for the highest-CDI-risk drug in your regimen. If you are on clindamycin plus cephalexin, take the clindamycin-recommended S. boulardii. If you are on Augmentin plus doxycycline, take LGG at the Augmentin dose (20 billion CFU). The two-hour spacing rule applies to each antibiotic dose individually.

Does Saccharomyces boulardii actually prevent C. difficile?

Yes, with an important nuance. Goldenberg’s 2017 Cochrane meta-analysis found a 60 percent relative risk reduction overall (relative risk 0.40, confidence interval 0.30 to 0.52).^[6] But the effect was driven mostly by patients whose baseline C. difficile risk was already above 5 percent (high-risk antibiotics like clindamycin, elderly hospitalized patients). For a young adult on amoxicillin for sinusitis, the absolute risk reduction is small. For a 70-year-old on clindamycin, it is large. The recommendation is most useful where you actually need it.

What’s the difference between Lactobacillus rhamnosus GG and other Lactobacillus strains?

LGG (also designated ATCC 53103) is a specific strain isolated by Sherwood Gorbach and Barry Goldin at Tufts in 1983 (the “GG” is their initials). It has acid and bile stability, strong adhesion to intestinal mucosa, and 800+ studies behind it. Most other L. rhamnosus strains do not share those characteristics. “Contains Lactobacillus rhamnosus” on a label is not the same as “contains L. rhamnosus GG.”

Can I take probiotics if I’m pregnant or breastfeeding?

Generally yes for routine outpatient probiotic use, but discuss with your obstetrician for any specific recommendation. The strain-specific safety data is best for LGG and S. boulardii in pregnancy. Avoid high-dose multistrain combinations in pregnancy without medical guidance.

Why do some studies show probiotics don’t help?

The most important honest answer in this article. The 2013 PLACIDE trial randomized 2,941 elderly UK inpatients on antibiotics to a multistrain Lactobacillus and Bifidobacterium probiotic at 60 billion CFU per day or placebo, and found no benefit on either AAD (10.8 vs. 10.4 percent) or C. difficile diarrhea (0.8 vs. 1.2 percent).^[15] Why does this matter? Because probiotic effects are highly strain-specific and population-specific. PLACIDE used a generic multistrain combination in a population with low baseline CDI risk. The trials that show clear benefit used specific strains (LGG, S. boulardii CNCM I-745, Bio-K+ CL1285) at validated doses in higher-risk populations. Probiotics work for some people on some antibiotics with some strains. They are not magic for everyone, and the article would be dishonest not to surface this.

Bottom Line

Match the probiotic strain to the antibiotic class. Saccharomyces boulardii for clindamycin, macrolides, and fluoroquinolones (the high-CDI-risk drugs where you want the yeast that survives antibacterial coverage). Lactobacillus rhamnosus GG (Culturelle) for penicillins, cephalosporins, tetracyclines, and most other classes.

Take the probiotic two hours apart from the antibiotic dose, daily through the course, and continue for two to four weeks after.

Most outpatient adults will do fine; immunocompromised patients, CVC patients, and critically ill patients should consult their doctor before adding anything. Yogurt and kefir are not substitutes for strain-specific clinical-dose probiotics during antibiotic courses, even though they are reasonable additions to a routine diet.

Probiotics are not magic, and any honest article on the topic has to disclose where the evidence is strong (clindamycin and S. boulardii for CDI prevention) and where it is thin (most class-specific RCTs do not exist; tetracyclines, Bactrim, and nitrofurantoin are class-extrapolated recommendations).

What this article gives you is the best version of the call you can make from the published evidence on the day you walk into the pharmacy.

Affiliate Disclosure: Some links in this article are affiliate links. If you buy a product through one of these links, MK Library earns a small commission at no additional cost to you. The recommendations are not influenced by the commission structure; the links point to the specific studied strains that have peer-reviewed evidence for the antibiotic in question. Where the evidence does not support a recommendation (Bactrim, Nitrofurantoin, single-dose Fosfomycin), the article says so and does not push a product.

Article Updates

May 24, 2026: Article published.

Sources

1. Becattini S, Taur Y, Pamer EG. Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends in Molecular Medicine. 2016;22(6):458-478. DOI
2. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. PNAS. 2011;108 Suppl 1:4554-4561. DOI
3. Palleja A, Mikkelsen KH, Forslund SK, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology. 2018;3(11):1255-1265. DOI
4. Korpela K, Salonen A, Virta LJ, et al. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nature Communications. 2016;7:10410. DOI
5. Bartlett JG. Antibiotic-associated diarrhea. N Engl J Med. 2002;346(5):334-339. DOI
6. Goldenberg JZ, Yap C, Lytvyn L, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2017;12:CD006095. DOI
7. Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326-2332. DOI
8. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-2449. DOI
9. McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the IDSA and SHEA. Clin Infect Dis. 2018;66(7):e1-e48. DOI
10. Johnson S, Lavergne V, Skinner AM, et al. IDSA/SHEA: 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021;73(5):e1029-e1044. DOI
11. Su GL, Ko CW, Bercik P, et al. AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 2020;159(2):697-705. DOI
12. Preidis GA, Weizman AV, Kashyap PC, Morgan RL. AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. 2020;159(2):708-738. DOI
13. Hempel S, Newberry SJ, Maher AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012;307(18):1959-1969. DOI
14. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101(4):812-822. DOI
15. Allen SJ, Wareham K, Wang D, et al. Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2013;382(9900):1249-1257. DOI
16. McFarland LV, Evans CT, Goldstein EJC. Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 2018;5:124. DOI
17. Williams NT. Probiotics. American Journal of Health-System Pharmacy. 2010;67(6):449-458. DOI
18. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149-1157. DOI
19. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015;42(7):793-801. DOI
20. McFarland LV, Surawicz CM, Greenberg RN, et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA. 1994;271(24):1913-1918. DOI
21. Maziade PJ, Pereira P, Goldstein EJC. A Decade of Experience in Primary Prevention of Clostridium difficile Infection at a Community Hospital Using the Probiotic Combination Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, and Lactobacillus rhamnosus CLR2 (Bio-K+). Clin Infect Dis. 2015;60 Suppl 2:S144-S147. DOI
22. Gao XW, Mubasher M, Fang CY, Reifer C, Miller LE. Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol. 2010;105(7):1636-1641. DOI
23. Vervoort J, Xavier BB, Stewardson A, et al. Metagenomic analysis of the impact of nitrofurantoin treatment on the human faecal microbiota. J Antimicrob Chemother. 2015;70(7):1989-1992. DOI
24. Louie TJ, Cannon K, Byrne B, et al. Fidaxomicin preserves the intestinal microbiome during and after treatment of CDI and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis. 2012;55 Suppl 2:S132-S142. DOI
25. Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364(1):22-32. DOI
26. Oh CK, Chung HH, Kim YJ, Kim JB, Lee JG. Comparison of rifaximin monotherapy and rifaximin combined with probiotics in patients with irritable bowel syndrome: A randomized controlled trial. Nutrients. 2025;17(5):763. DOI
27. Cassone M, Serra P, Mondello F, et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol. 2003;41(11):5340-5343. DOI
28. Muñoz P, Bouza E, Cuenca-Estrella M, et al. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11):1625-1634. DOI
29. Lolis N, Veldekis D, Moraitou H, et al. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit Care. 2008;12(2):414. DOI
30. Rannikko J, Holmberg V, Karppelin M, et al. Fungemia and Other Fungal Infections Associated with Use of Saccharomyces boulardii Probiotic Supplements. Emerging Infectious Diseases. 2021;27(8):2043-2051. DOI
31. Besselink MGH, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-659. DOI
32. CDC. Outpatient Antibiotic Prescriptions, United States, 2022. Atlanta: Centers for Disease Control and Prevention; 2024. Link
33. Szajewska H, Canani RB, Guarino A, et al.; ESPGHAN Working Group for Probiotics/Prebiotics. Probiotics for the prevention of antibiotic-associated diarrhea in children. J Pediatr Gastroenterol Nutr. 2016;62(3):495-506. DOI
34. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2015;(12):CD004827. DOI